View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
Although many experts warn clinicians not to substitute brand-name cardiovascular drugs with generics, results from an extensive literature review of available evidence raises questions about this conventional wisdom. Surveying peer- reviewed publications from January 1984 to August 2008, researchers compared generic and brand-name cardiovascular drugs for safety and effectiveness. They found clinical equivalence in all randomized controlled trials for beta-blockers, alpha-blockers, statins, antiplatelet agents, and angiotensin- converting enzyme (ACE) inhibitors. In addition, they found equivalence in 91% of trials involving diuretics and 71% of those involving calcium channel blockers. However, the number of trials studied for some drug categories was small (three or less).
Noting that use of generic drugs can significantly cut drug costs, the researchers concluded that the evidence doesn't support the superiority of brand-name drugs. Yet over half of 43 editorials in peer-reviewed journals expressed a "negative view" of generic substitutions. Nearly all failed to disclose funding sources.
Source: Kesselheim AS, Misono AS, Lee JL, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514-2526.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top